Frontlight ResearchEarly access
Pancreatic cancer trials in Australia
50 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- East Melbourne, Heidelberg, Herston, Kogarah, Randwick, Waratah
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445 · EU 2025-525088-34-00 - Phase 2Taking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Melbourne, Murdoch, Randwick
- Age
- 18 years and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - Phase 1/2Taking peopleEvaluation of XYA02 in Patients With Advanced Solid Tumors
- Where
- Melbourne, Perth, Sydney
- Age
- 18 years and over
- People
- 190
- Run by
- XYone Therapeutics, Inc
See details and how to joinNCT07670312 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- Adelaide, Brisbane, Camperdown, Geelong, Sydney
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - Phase 1/2Not yet taking people in AustraliaStudy of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Where
- Bedford Park, Blacktown, Heidelberg, Nedlands, Randwick, Sydney
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Betta Pharmaceuticals Co., Ltd.
See details and how to joinNCT07435038 - Phase 1/2Taking peopleSL-28 for Advanced Solid Tumours
- Where
- Adelaide, Gold Coast, Sydney
- Age
- 18 years and over
- People
- 60
- Run by
- Second Life Therapeutics
See details and how to joinNCT07341737 - No phaseTaking peopleBiospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
- Where
- Randwick
- Age
- Up to 17 years
- People
- 1,600 worldwide
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06651580 - Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1/2Taking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Melbourne, Sydney
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - Phase 1/2Taking peopleA Study of DM002 in Patients With Advanced Solid Tumors
- Where
- Adelaide, Randwick, Wollongong
- Age
- 18 years and over
- People
- 280 worldwide
- Run by
- Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
See details and how to joinNCT06751329 - Phase 1Taking peopleIDOV-Immune for Advanced Solid Tumors
- Where
- Melbourne, Westmead
- Age
- 18 years and over
- People
- 78 worldwide
- Run by
- ViroMissile, Inc.
See details and how to joinNCT06910657 - Phase 1Taking peopleAMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Camperdown, Melbourne, Woodville South
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113 - Phase 2Taking peopleA Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer
- Where
- Bedford Park, Benowa, Frankston, Melbourne, Mount Pleasant, Saint Leonards, Sunshine Coast, Sydney
- Age
- 18 years and over
- People
- 105 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07255404 - Phase 1Taking peopleA Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Camperdown, Darlinghurst, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160 · EU 2023-507091-47-00 - Phase 1Taking peopleBBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Where
- Melbourne
- Age
- 18 years and over
- People
- 665 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06917079 - Phase 1Taking peopleA Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
- Where
- Adelaide, Ryde, Sydney, Westmead
- Age
- 18 years and over
- People
- 36
- Run by
- EtiraRx Australia Pty Ltd
See details and how to joinNCT06533332 - No phaseTaking peopleLEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
- Where
- Melbourne, Saint Leonards, Woolloongabba
- Age
- 18 years and over
- People
- 300
- Run by
- University of Sydney
See details and how to joinNCT05184790 - Phase 1Not yet taking people in AustraliaSafety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)
- Where
- Adelaide
- Age
- 18 years to 85 years
- People
- 10
- Run by
- NRT MedTech Australia Pty Ltd
See details and how to joinNCT07555587 - Phase 1/2Taking peopleEarly Phase Study of KESONOTIDE™in Participants With Solid Tumours
- Where
- Kogarah, Liverpool, Miranda
- Age
- 18 years and over
- People
- 80
- Run by
- Filamon LTD
See details and how to joinNCT06926075 - No phaseNot yet taking people in AustraliaThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Melbourne
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - Phase 1/2Taking peopleA Study of PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.
- Where
- Frankston
- Age
- 18 years to 89 years
- People
- 130 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06907043 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Melbourne
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - Phase 2/3Taking peopleStudy of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Where
- Garran, Heidelberg, Kurralta Park, Murdoch, Tweed Heads
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Panbela Therapeutics, Inc.
See details and how to joinNCT05254171 · EU 2024-514714-12-00 - No phaseTaking peopleIntraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
- Where
- Fitzroy
- Age
- 18 years to 90 years
- People
- 1,000
- Run by
- St Vincent's Hospital Melbourne
See details and how to joinNCT05117723 - Phase 1Taking peopleStudy of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors
- Where
- Bedford Park, Darlinghurst, Malvern, Nedlands, Randwick, Westmead
- Age
- 18 years and over
- People
- 48
- Run by
- Myeloid Therapeutics
See details and how to joinNCT05969041